Home » Learning Objectives, Pharmacogenetics, TCPR, October 2014

Learning Objectives, Pharmacogenetics, TCPR, October 2014

October 1, 2014

After reading these articles, you should be able to:

Determine some of the pharmacogenetic tests that can possibly play a role in clinical psychiatry.

Describe the uses of pharmacogenetic testing and reasons why a psychiatrist would consider genetic testing on patients.

Explain what is known about the new insomnia drug suvorexant (Belsomra), which was approved by the FDA.

Summarize some of the current findings in the literature regarding psychiatric treatment.

General Psychiatry

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)
Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

General Psychiatry
Pregnancy and PMDD at the Mood Summit
Today we’ll bring you up to date on how to manage premenstrual dysphoric disorder and safe prescribing during pregnancy with a little help from Anita Clayton.
Listen now

Approaches to Autism Intervention
January 31, 2022
Currently Available Cannabis Products
September 1, 2022
Interpreting Assessment Discrepancies from Multiple Sources
October 17, 2022

Approaches to Autism Intervention
January 31, 2022
Currently Available Cannabis Products
September 1, 2022
Interpreting Assessment Discrepancies from Multiple Sources
October 17, 2022

Approaches to Autism Intervention
January 31, 2022
Currently Available Cannabis Products
September 1, 2022
Interpreting Assessment Discrepancies from Multiple Sources
October 17, 2022